Dominique DJOMO TAMCHOM

Dominique DJOMO TAMCHOM


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025
Verified
Preprint
Open access
DTDominique DJOMO TAMCHOM
Dominique DJOMO TAMCHOM
ELEric Bila Lamou
Eric Bila Lamou
BNBerinyuy Nyuydzefon
Berinyuy Nyuydzefon
BKBertolt Brecht Kouam
Bertolt Brecht Kouam
VSVerla Siysi
Verla Siysi

23 November 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
DTDominique DJOMO TAMCHOM
Dominique DJOMO TAMCHOM
AKAristide Kuitchet
Aristide Kuitchet
RNRaymond Ndikontar
Raymond Ndikontar
SNSerge Nga Nomo
Serge Nga Nomo
HFHermine Fouda
Hermine Fouda
LOluc Van Obbergh
luc Van Obbergh
Patients with sickle cell disease are more likely to undergo surgery during their lifetime, especially given the numerous complications they may develop. There is a paucity of data concerning the management of patients with sickle cell disease by anaesthesiologists, especially in Africa. This study aimed to describe the practices of anaesthesiologists in Cameroon concerning the perioperative management of patients with sickle cell disease. A cross-sectional study was carried out over four months and involved 35 out 47 anaesthesiologists working in hospitals across the country, who were invited to fill a data collection form after giving their informed consent. The data were analysed using descriptive statistics and a binary logistic regression model. Among the 35 anaesthesiologists included in the study, most (29 (82.9%)) had managed patients with sickle cell disease for both emergency and elective surgical procedures. Most of them had never asked for a haematology consultation before surgery. Most participants (26 (74.3%)) admitted to having carried out simple blood transfusions, while 4 (11.4%) carried out exchange transfusions. The haemoglobin thresholds for transfusion varied from one practitioner to another, between <6 g/dL and <9 g/dL. Only 6 (17.1%) anaesthesiologists had a treatment guideline for the management of patients with sickle cell disease in the hospitals where they practiced. Only 9 (25.7%) prescribed a search for irregular agglutinins. The percentage of haemoglobin S before surgery was always available for 5 (14.3%) of the participants. The coefficient (0.06) of the occurrence of a haematology consultation before surgery had a significant influence on the probability of management of post-operative complications (coefficient 0.06, 10% level of probability). This study highlights the fact that practices in the perioperative management of patients with sickle cell disease in Cameroon vary greatly from one anaesthesiologist to another. We disclosed major differences in the current recommendations, which support the fact that even in Sub-Saharan countries, guidelines applicable to the local settings should be published.

1 February 2022 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
DTDominique DJOMO TAMCHOM
Dominique DJOMO TAMCHOM
BEBasile Essola
Basile Essola
AKAristide Kuitchet
Aristide Kuitchet
RNRaymond Ndikontar
Raymond Ndikontar
SNSerge Nga Nomo
Serge Nga Nomo
LOluc Van Obbergh
luc Van Obbergh